Early research suggested it promoted fat storage
This bypasses first-pass metabolism in the liver and avoids the stomach entirely
Furthermore, it significantly decreased aldosterone concentrations, a known predictor of increased cardiovascular mortality risk, which would indicate AT1R blockade ( Finally, the prevalence of primary aldosteronism (PA), the most common form of secondary hypertension, is reported to be 11-14% in patients with diabetes and hypertension
And for people taking GLP-1s, that muscle loss tends to be more pronounced
This means that more insulin is needed to move glucose into the cells, which can eventually lead to high blood sugar levels and the development of type 2 diabetes
Consumers have changed their food buying habits because they are feeling economically stressed, and also because they are watching how much and what they eat by taking GLP-1 weight loss drugs and focusing on their wellness, a key market analyst said here last week at the International Sweetener Colloquium